G. Patrick Maxwell
Corporate Officer/Principal bei Vanderbilt University
Profil
G.
Patrick Maxwell is the founder of Gid Bio Inc. (founded in 2010).
He is currently a Professor at Vanderbilt University (since 2009).
He has formerly worked as a Clinical Director at Inamed Corp., Director at Precision Light, Inc., Director at AEON Biopharma Sub, Inc., Chief Surgical Officer & Executive Vice President at Diversified Specialty Institutes, Inc., Principal at Baptist Hospital (Tennessee), and Professor at Plastic Surgery Education Foundation.
Dr. Maxwell obtained his doctorate degree from Vanderbilt University in 1972.
Aktive Positionen von G. Patrick Maxwell
| Unternehmen | Position | Beginn |
|---|---|---|
| Vanderbilt University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von G. Patrick Maxwell
| Unternehmen | Position | Ende |
|---|---|---|
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Direktor/Vorstandsmitglied | - |
Gid Bio Inc.
 Gid Bio Inc. Medical/Nursing ServicesHealth Services Gid Bio Inc. develops next-generation cellular therapies for degenerative musculoskeletal, dermal, and organ specific diseases. The company is based in Louisville, CO. The technology uniquely isolates and concentrates a cellular implant that is administered by injection in a physician's office under image guidance. The company has been granted two CPT Class III codes, a step toward Medicare reimbursement. Gid Bio's SVF-2 technology and point-of-care therapy harness the innate power of a patient's own stromal cells. The company was founded in 2010 by Adam J. Katz, G. Patrick Maxwell, Ramon Llull, J. William Futrell. The CEO is William W. Cimino. | Gründer | - |
Precision Light, Inc.
 Precision Light, Inc. Medical SpecialtiesHealth Technology Precision Light, Inc. develops 3D imaging systems which are used by plastic surgeons to enhance breast augmentation surgery. The company was founded by David Mordaunt on February 19, 2008 and is headquartered in Los Gatos, CA. | Direktor/Vorstandsmitglied | - |
Inamed Corp.
 Inamed Corp. Medical SpecialtiesHealth Technology Inamed Corp. developed and manufactured breast implants, wrinkle prevention & obesity solutions. Its products were available through its two business divisions: INAMED Aesthetics, and INAMED Health. The company offered breast implants for augmentation, reconstruction surgeries, invasive surgeries for sustained weight loss and other dermal products to correct facial wrinkles. INAMED was headquartered in Santa Barbara, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Baptist Hospital (Tennessee)
 Baptist Hospital (Tennessee) Hospital/Nursing ManagementHealth Services Baptist Hospital (Tennessee) provides healthcare services. The company offers services in the areas of cancer, cardiac, and diabetes. Its services include rehabilitation and childbirth services. Baptist Hospital was founded in 1918 and is headquartered in Nashville, TN. | Corporate Officer/Principal | - |
Ausbildung von G. Patrick Maxwell
| Vanderbilt University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Inamed Corp.
Inamed Corp. Medical SpecialtiesHealth Technology Inamed Corp. developed and manufactured breast implants, wrinkle prevention & obesity solutions. Its products were available through its two business divisions: INAMED Aesthetics, and INAMED Health. The company offered breast implants for augmentation, reconstruction surgeries, invasive surgeries for sustained weight loss and other dermal products to correct facial wrinkles. INAMED was headquartered in Santa Barbara, CA. | Health Technology |
Diversified Specialty Institutes, Inc.
 Diversified Specialty Institutes, Inc. Hospital/Nursing ManagementHealth Services Diversified Specialty Institutes, Inc. provided dialysis healthcare services. The company was founded in 2003 and was headquartered in Nashville, TN. | Health Services |
Precision Light, Inc.
Precision Light, Inc. Medical SpecialtiesHealth Technology Precision Light, Inc. develops 3D imaging systems which are used by plastic surgeons to enhance breast augmentation surgery. The company was founded by David Mordaunt on February 19, 2008 and is headquartered in Los Gatos, CA. | Health Technology |
Baptist Hospital (Tennessee)
Baptist Hospital (Tennessee) Hospital/Nursing ManagementHealth Services Baptist Hospital (Tennessee) provides healthcare services. The company offers services in the areas of cancer, cardiac, and diabetes. Its services include rehabilitation and childbirth services. Baptist Hospital was founded in 1918 and is headquartered in Nashville, TN. | Health Services |
| Plastic Surgery Education Foundation | |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Health Technology |
Gid Bio Inc.
Gid Bio Inc. Medical/Nursing ServicesHealth Services Gid Bio Inc. develops next-generation cellular therapies for degenerative musculoskeletal, dermal, and organ specific diseases. The company is based in Louisville, CO. The technology uniquely isolates and concentrates a cellular implant that is administered by injection in a physician's office under image guidance. The company has been granted two CPT Class III codes, a step toward Medicare reimbursement. Gid Bio's SVF-2 technology and point-of-care therapy harness the innate power of a patient's own stromal cells. The company was founded in 2010 by Adam J. Katz, G. Patrick Maxwell, Ramon Llull, J. William Futrell. The CEO is William W. Cimino. | Health Services |
